Sheldon L. Koenig - President and CEO, Director at Esperion Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sheldon L. Koenig - trading volume in the past year for Esperion Therapeutics, Inc.

Holdings reported by Sheldon L. Koenig for Esperion Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 752K $1.35M $1.80 Sep 17, 2024 Direct
Stock Option (right to buy) 642K $1.04M $1.62 Mar 14, 2024 Direct Common Stock 492K

Transactions reported by Sheldon L. Koenig for Esperion Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.